Intellectual Property Committee
This committee provides advice to CGPA on issues related to Canada’s pharmaceutical patent regime.
Chair: Kevin Zive, Apotex
Vice-Chair: Shona Mcdiarmid, Pharmascience
Market Growth Committee
This committee develops strategies to facilitate the increase in generic pharmaceutical sales in Canada and internationally. This group benchmarks international practices and develops options for companies to increase private sector market share.
Chair: Heather J. West, Apotex
Vice-Chair: Houri Ohan, Teva
Government Relations Committee
The committee assists CGPA in its communications with all levels of government.
Chair: Jason Soler, Teva
Vice-Chair: Gayle Peddle, Taro
Scientific Affairs Committee
This committee is responsible for liaising with, and providing input to, Health Canada on various scientific issues related to the approval of generic pharmaceuticals at the federal level.
Chair: Len Arsenault, Sandoz
Vice-Chair: Mathi Mathivanan, Teva
Industry Practices Review Board – Quebec
This board is responsible for the education, compliance and enforcement activities required for the implementation of CGPA’s code of marketing conduct in Quebec.